Between two cultures: The expert clinician and the pharmaceutical industry

Clinical Medicine

Volumn 3, Issue 6, 2003, Pages 538-541

  Gale, Edwin A M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Conflict of interest; Sponsorship

Indexed keywords

CLINICAL PRACTICE; CONSULTATION; CULTURAL FACTOR; DOCTOR PATIENT RELATION; DRUG INDUSTRY; ETHICS; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH SERVICE; PATIENT CARE; PROFESSIONAL PRACTICE; REVIEW;

EID: 0348142059     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-6-538     Document Type: Review

References (4)

1. Gale EAM. The glitazones: a story of drug development. Lancet 2001; 357:1870-5.
2. Frantz S, Smith A. New drug approvals for 2002. Nature Reviews/Drug Discovery 2003;2:95-6.
3. Boorstin, Daniel J. The image, or what happened to the American dream. New York: Atheneum, 1962.
4. Machiavelli, N. The prince. Translated by John Bull. London: Penguin Books, 1969.